SHS MILLENDO THERA OVAS
Set alert
At close · Jun 28
52-week range unavailable
- Open
- 0.73
- Prev close
- 0.69
- Mkt cap
- 0
- Vol
- 100.53K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.69
- High
- 0.77
News
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, September 14
Stocks Which Set New 52-Week Low Friday, September 14
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, September 12th
Stocks Which Set New 52-Week Low Yesterday, September 12th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, September 11th
Stocks Which Set New 52-Week Low Yesterday, September 11th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, August 9th
Stocks Which Set New 52-Week Low Yesterday, August 9th
8 years ago businesswire.com
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
WALTHAM, Mass. & ANN ARBOR, Mich.--(BUSINESS WIRE)--OvaScienceSM (Nasdaq:OVAS) and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel…
8 years ago businesswire.com
OvaScience to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScience℠ (NASDAQ: OVAS), a company focused on the discovery, development and commercialization of new treatment options for women and families struggling with…
9 years ago businesswire.com
OvaScience to Host Third Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will…
9 years ago businesswire.com
OvaScience to Host Second Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will…
9 years ago businesswire.com
OvaScience to Host First Quarter 2017 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it…
9 years ago businesswire.com
OvaScience to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it…
10 years ago businesswire.com
OvaScience to Host Third Quarter 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it…
10 years ago businesswire.com
OvaScience to Host Second Quarter 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it…
10 years ago businesswire.com
OvaScience to Host First Quarter 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it…
10 years ago businesswire.com
OvaScience to Host Fourth Quarter and Fiscal Year 2015 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it…
11 years ago businesswire.com
OvaScience Provides Update on Corporate Goal for AUGMENT Treatment
CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that…
11 years ago businesswire.com
Improved Pregnancy Rates and Healthy Births with OvaScience’s AUGMENT Fertility Treatment to be Published in Peer-Reviewed Journal
CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that a…
11 years ago businesswire.com
OvaScience to Host Conference Call and Webcast Presentation with IVF Specialists to Review Early AUGMENT Fertility Treatment Patient Experience
CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today a…